Activation profiles of HSPA5 during the glomerular mesangial cell stress response to chemical injury

Cell Stress and Chaperones

Volumn 12, Issue 3, 2007, Pages 209-218

  Falahatpisheh, Hadi ^a   Nanez, Adrian ^a   Montoya Durango, Diego ^a   Qian, Yongchang ^b   Tiffany Castiglioni, Evelyn ^b   Ramos, Kenneth S ^a  

^a University of Louisville School of Medicine   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; DACTINOMYCIN; GLUCOSE REGULATED PROTEIN 78; LEAD ACETATE; MERCURY CHLORIDE; MESSENGER RNA; THAPSIGARGIN; CHAPERONE; CYCLOHEXIMIDE; HEAT SHOCK PROTEIN; HSPA5 PROTEIN, RAT; MERCURIC CHLORIDE; MOLECULAR CHAPERONE GRP78; NUCLEIC ACID SYNTHESIS INHIBITOR; ORGANOMETALLIC COMPOUND; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CELL STRESS; CHEMICAL INJURY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECT; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROMOTER REGION; RAT; RNA PROCESSING; STRESS;

MURINAE; RATTUS;

ANIMALS; BENZO(A)PYRENE; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; HUMANS; MERCURIC CHLORIDE; MESANGIAL CELLS; MICE; MOLECULAR CHAPERONES; NUCLEIC ACID SYNTHESIS INHIBITORS; ORGANOMETALLIC COMPOUNDS; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; RATS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; STRESS; THAPSIGARGIN; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 35348913119     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1379/CSC-259.1     Document Type: Article

References (72)

1. [ATSDR] Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for Mercury. Department of Human Health Services, Washington, DC.
2. ATSDR. 2005. Toxicological Profile for Lead. Department of Human Health Services. Washington, DC.
3. Baker EL Jr, Goyer RA, Fowler BA, et al. 1980. Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med 1: 139-148.
4. Baqui MMA, Gereben B, Harney JW, Larsen PR, Bianco AC. 2000. Distinct subcellular localization of transiently expressed types 1 and 2 Iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141: 4309-4312.
5. Baser ME, Marion D. 1990. A statewide case registry for surveillance of occupational heavy metals absorption. Am J Public Health 80: 162-164.
6. Baumeister P, Luo S, Skarnes WC, Sui G, Seto E, Shi Y, Lee AS. 2005. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol 25: 4529-4540.
7. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2: 326-332.
8. Biagini G, Misciattelli ME, Contri Baccarani M, Vangelista A, Raffi GB, Caudarella R. 1977. [Electron microscopy features of renal changes in chronic lead poisoning]. Lav Um 29: 179-187. [in Italian].
9. Blayney MB. 2001. The need for empirically derived permeation data for personal protective equipment: the death of Dr. Karen E. Wetterhahn. Appl Occup Environ Hyg 16: 233-236.
10. Bowes I, Russell C., Parrish AR, et al. 1996. Atypical cytochrome P450 induction profiles in glomerular mesangial cells at the mRNA and enzyme level : evidence for CYP1A1 and CYP1B1 expression and their involvement in benzo[a]pyrene metabolism. Biochem Pharmacol 52: 587-595.
11. Bral CM, Ramos KS. 1997. Identification of benzo[a]pyrene- inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol Pharmacol 52: 974-982.
12. Brooks DA. 1997. Protein processing: a role in the pathophysiology of genetic disease. FEBS Lett 409: 115-120.
13. Busbee DL, Norman JO, Ziprin RL. 1990. Comparative uptake, vascular transport, and cellular internalization of aflatoxin-B1 and benzo(a) pyrene. Arch Toxicol 64: 285-290.
14. Chang SC, Wooden SK, Nakaki T, et al. 1987. Rat gene encoding the 78-kDa glucose-regulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression. PNAS 84: 680-684.
15. Cramer K, Goyer RA, Jagenburg R, Wilson MH. 1974. Renal ultrastructure, renal function, and parameters of lead toxicity in workers with different periods of lead exposure. Br J Ind Med 31: 113-127.
16. Degawa M, Arai H, Kubota M, Hashimoto Y. 1994. Ionic lead, a unique metal ion as an inhibitor for cytochrome P450IA2 (CYP1A2) expression in the rat liver. Biochem Biophys Res Commun 200: 1086-1092.
17. Dhakshinamoorthy S, Long DJ 2nd, Jaiswal AK. 2000. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36: 201-216.
18. Diamond GL. 2005. Risk assessment of nephrotoxic metals. In: The Toxicology of the Kidney, ed Tarloff J, Lash L. CRC Press, London, 1099-1132.
19. dos Santos AC, Colacciopo S, Dal Bo CM, dos Santos NA. 1994. Occupational exposure to lead, kidney function tests, and blood pressure. Am J Ind Med 26: 635-643.
20. Florea AM, Busselberg D. 2006. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 19: 419-427.
21. Gething M-J. 1999. Role and regulation of the ER chaperone BiP*1. Sem Cell Devel Biol 10: 465-472.
22. Goyer RA. 1989. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett 46: 153-162.
23. Goyer RA, Rhyne BC. 1973. Pathological effects of lead. Int Rev Exp Pathol 12: 1-77.
24. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
25. Gulow K, Bienert D, Haas IG. 2002. BiP is feed-back regulated by control of protein translation efficiency. J Cell Sci 115: 2443-2452.
26. Hansen JC, Jensen TG, Tarp U. 1991. Changes in blood mercury and lead levels in pregnant women in Greenland 1983-1988. Arctic Med Res x(Suppl): 605-607.
27. Henry GA, Jarnot BM, Steinhoff MM, Bigazzi PE. 1988. Mercury-induced renal autoimmunity in the MAXX rat. Clin Immunol Immunopathol 49: 187-203.
28. Hirszel P, Michaelson JH, Dodge K, Yamase H, Bigazzi PE. 1985. Mercury-induced autoimmune glomerulonephritis in inbred rats. II. Immunohistopathology, histopathology and effects of prostaglandin administration. Surv Synth Pathol Res 4: 412-422.
29. Hong CD, Hanenson IB, Lerner S, Hammond PB, Pesce AJ, Pollak VE. 1980. Occupational exposure to lead: effects on renal function. Kidney Int 18: 489-494.
30. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. 2006. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1{alpha}-mediated NF-{kappa}B activation and down-regulation of TRAF2 expression. Mol Cell Biol 26: 3071-3084.
31. Hung J-H, Su I-J, Lei H-Y, et al. 2004. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-{kappa}B and pp38 mitogen-activated protein kinase. J Biol Chem 279: 46384-46392.
32. Imai Y, Soda M, Takahashi R. 2000. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 275: 35661-35664.
33. Imaizumi K, Miyoshi K, Katayama T, Yoneda T, Taniguchi M, Kudo T, Tohyama M. 2001. The unfolded protein response and Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis 1536: 85-96.
34. Kimata Y, Kimata YI, Shimizu Y, et al. 2003. Genetic evidence for a role of BiP/Kar2 that regulates Ire1 in response to accumulation of unfolded proteins. Mol Biol Cell 14: 2559-2569.
35. Korashy HM, El-Kadi AO. 2004. Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology 201: 153-172.
36. Korashy HM, El-Kadi AO. 2006a. The role of aryl hydrocarbon receptor and the reactive oxygen species in the modulation of glutathione transferase by heavy metals in murine hepatoma cell lines. Chem Biol Interact 162: 237-248.
37. Korashy HM, El-Kadi AO. 2006b. Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper. Drug Metab Dispos 34: 152-165.
38. Krieger JA, Davila DR, Lytton J, Born JL, Burchiel SW. 1995. Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-All human T cells and other tissues. Toxicol Appl Pharmacol 133: 102-108.
39. Lam M, Vimmerstedt LJ, Schlatter LK, Hensold JO, Distelhorst CW. 1992. Preferential synthesis of the 78-Kd glucose-regulated protein in glucocorticoid-treated S49 mouse lymphoma cells. Blood 79: 3285-3292.
40. Larsson SH, Charlieu JP, Miyagawa K, et al. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401.
41. Li W, Hsiung Y, Zhou Y, Roy B, Lee A. 1997. Induction of the mammalian GRP78/BiP gene by Ca2+ depletion and formation of aberrant proteins: activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1. Mol Cell Biol 17: 54-60.
42. Lilis R, Gavrilescu N, Nestorescu B, Dumitriu C, Roventa A. 1968. Nephropathy in chronic lead poisoning. Br J Ind Med 25: 196-202.
43. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. 1994. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr 4: 1-18.
44. Liu J-S, Kuo S-R, Makhov AM, Cyr DM, Griffith JD, Broker TR, Chow LT. 1998. Human Hsp70 and Hsp40 chaperone proteins facilitate human papillomavirus-11 E1 protein binding to the origin and stimulate cell-free DNA replication. J Biol Chem 273: 30704-30712.
45. Loghman-Adham M. 1997. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 105: 928-939.
46. Luo S, Baumeister P, Yang S, Abcouwer SF, Lee AS. 2003. Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. J Biol Chem 278: 37375-37385.
47. Magos L, Sparrow S, Snowden RT. 1984. Effect of prolonged saline loading on HgCl2-induced renal tubular damage. Br J Exp Pathol 65: 567-575.
48. Mao C, Tai W-C, Bai Y, Poizat C, Lee AS. 2006. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J Biol Chem 281: 8877-8887.
49. Michalak M, Robert Parker JM, Opas M. 2002. Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32: 269-278.
50. Pain VM. 1996. Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 236: 747-771.
51. Parrish A, Alejandro N, Bowes R III, Ramos K. 1998. Cytotoxic response profiles of cultured renal epithelial and mesenchymal cells to selected aromatic hydrocarbons. Toxicol In Vitro 12: 219-232.
52. Prostko CR, Brostrom MA, Malara EM, Brostrom CO. 1992. Phosphorylation of eukaryotic initiation factor (eIF) 2 alpha and inhibition of eIF-2B in GH3 pituitary cells by perturbants of early protein processing that induce GRP78. J Biol Chem 267: 16751-16754.
53. Qian Y, Falahatpisheh MH, Zheng Y, Ramos KS, Tiffany-Castiglioni E. 2001. Induction of 78 kD glucose-regulated protein (GRP78) expression and redox-regulated transcription factor activity by lead and mercury in C6 rat glioma cells. Neurotox Res 3: 581-589.
54. Qian Y, Mikeska G, Harris ED, Bratton GR, Tiffany-Castiglioni E. 1999. Effect of lead exposure and accumulation on copper homeostasis in cultured C6 rat glioma cells. Toxicol Appl Pharmacol 158: 41-49.
55. Qian Y, Tiffany-Castiglioni E, Harris ED. 1995. Copper transport and kinetics in cultured C6 rat glioma cells. Am J Physiol 269: C892-C898.
56. Qian Y, Zheng Y, Ramos KS, Tiffany-Castiglioni E. 2005a. GRP78 compartmentalized redistribution in Pb-treated glia: role of GRP78 in lead-induced oxidative stress. Neurotoxicology 26: 267-275.
57. Qian Y, Zheng Y, Ramos KS, Tiffany-Castiglioni E. 2005b. The involvement of copper transporter in lead-induced oxidative stress in astroglia. Neurochem Res 30: 429-438.
58. Rao RV, Peel A, Logvinova A, et al. 2002. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514: 122-128.
59. Resendez EJ, Wooden SK, Lee AS. 1988. Identification of highly conserved regulatory domains and protein-binding sites in the promoters of the rat and human genes encoding the stress-inducible 78-kilodalton glucose-regulated protein. Mol Cell Biol 8: 4579-4580.
60. Roy B, Li WW, Lee AS. 1996. Calcium-sensitive transcriptional activation of the proximal CCAAT regulatory element of the grp78/BiP promoter by the human nuclear factor CBF/NF-Y. J Biol Chem 271: 28995-29002.
61. Sharma RK, Agrawal M. 2005. Biological effects of heavy metals: an overview. J Environ Biol 26: 301-313.
62. Shelton KR, Todd JM, Egle PM. 1986. The induction of stress-related proteins by lead. J Biol Chem 261: 1935-1940.
63. Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE. 2000. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharmacol 168: 79-90.
64. Ubeda M, Habener JF. 2000. CHOP gene expression in response to endoplasmic-reticular stress requires NFY interaction with different domains of a conserved DNA-binding element. Nucleic Acids Res 28: 4987-4997.
65. Ulatowski LM, Lam M, Vanderburg G, Stallcup MR, Distelhorst CW. 1993. Relationship between defective mouse mammary tumor virus envelope glycoprotein synthesis and GRP78 synthesis in glucocorticoid-treated mouse lymphoma cells. Evidence for translational control of GRP78 synthesis. J Biol Chem 268: 7482-7488.
66. [USEPA] US Environmental Protection Agency. 1990. Toxicological Profile for Polycyclic Aromatic Hydrocarbons. USEPA PB 91-181537, Washington, DC.
67. Verberk MM, Willems TE, Verplanke AJ, De Wolff FA. 1996. Environmental lead and renal effects in children. Arch Environ Health 51: 83-87.
68. Wedeen RP, Maesaka JK, Weiner B, Lipat GA, Lyons MM, Vitale LF, Joselow MM. 1975. Occupational lead nephropathy. Am J Med 59: 630-641.
69. Wedeen RP, Malik DK, Batuman V. 1979. Detection and treatment of occupational lead nephropathy. Arch Intern Med 139: 53-57.
70. Wei YD, Tepperman K, Huang MY, Sartor MA, Puga A. 2004. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J Biol Chem 279: 4110-4119.
71. [WHO] World Health Organization. 1990. Biennial Report of the Director-General to the World Health Assembly and to the United Nations. WHO, Geneva, Switzerland.
72. Wooden SK, Li LJ, Navarro D, Qadri I, Pereira L, Lee AS. 1991. Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol Cell Biol 11: 5612-5623.